ื”ืขื“ืคืชื›ื ืขื•ื“ื›ื ื” ืขื‘ื•ืจ ื”ืžืคื’ืฉ ื”ื–ื”. ื›ื“ื™ ืœืฉื ื•ืช ืืช ื”ื’ื“ืจืช ื”ื—ืฉื‘ื•ืŸ ืœืฆืžื™ืชื•ืช, ืขื‘ืจื• ืืœ
ืœื”ื–ื›ื™ืจื›ื, ื ื™ืชืŸ ืœืขื“ื›ืŸ ืืช ื”ืžื“ื™ื ื” ืื• ื”ืฉืคื” ื”ืžื•ืขื“ืคื•ืช ืขืœื™ื›ื ื‘ื›ืœ ืขืช ื‘
> beauty2 heart-circle sports-fitness food-nutrition herbs-supplements pageview
לחצו להצגת הצהרת הנגישות שלנו

מזונות שמעלים את רמות GLP-1

7,515 צפיות

anchor-icon תוכן העניינים dropdown-icon
anchor-icon תוכן העניינים dropdown-icon

ืžื” GLP-1 ืขื•ืฉื” ื‘ื’ื•ืฃ?

ื‘ืจื—ื‘ื™ ื”ืขื•ืœื ื™ื•ืชืจ ื•ื™ื•ืชืจ ืื ืฉื™ื ื ืขื–ืจื™ื ื‘ื”ื•ืจืžื•ื ื™ื ืžืกื•ื’ GLP-1 ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืžืฉืงืœ ื‘ืจื™ื. ื™ืฉ ืžื’ื•ื•ืŸ ืžื•ืฆืจื™ื ื‘ืฉื•ืง ืฉืžื™ื•ืขื“ื™ื ืœื•ื•ื™ืกื•ืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ืชื•ืš ื›ื“ื™ ื”ืฉืคืขื” ื—ื™ื•ื‘ื™ืช ืขืœ ื”ืžืฉืงืœ. ื”ืจื‘ื” ืžื”ืžื•ืฆืจื™ื ื”ืืœื” ืžื—ืงื™ื ื”ื•ืจืžื•ืŸ ื˜ื‘ืขื™ ืฉืžื•ืคืง ื‘ื’ื•ืฃ ื”ืื“ื ืฉื ืงืจื” ืคืคื˜ื™ื“ ื“ืžื•ื™-ื’ืœื•ืงื’ื•ืŸ-1 (GLP-1). ื”ื”ื•ืจืžื•ืŸ ื”ื–ื” ืžื•ืคืจืฉ ืขืœ ื™ื“ื™ ืชืื™ ืขืฆื‘ ืžืกื•ื™ืžื™ื ื‘ืžื•ื— ื•ืชืื™ L ื‘ืžืขื™ื™ื ืื—ืจื™ ืฆืจื™ื›ืช ืžื–ื•ืŸ.

ืื™ื–ื•ืŸ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื

ืœ-GLP-1 ื™ืฉ ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ื•ื•ื™ืกื•ืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื. ื”ื•ื•ื™ืกื•ืช ืžืชืจื—ืฉ ื”ื•ื“ื•ืช ืœื”ื’ื‘ืจืช ื”ื”ืคืจืฉืช ืฉืœ ืื™ื ืกื•ืœื™ืŸ ื•ื”ืคื—ืชืช ื”ื”ืคืจืฉื” ืฉืœ ื’ืœื•ืงื’ื•ืŸ. ืื™ื ืกื•ืœื™ืŸ ืžื•ืจื™ื“ ืืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ืขืœ ื™ื“ื™ ื”ืกืจืช ื’ืœื•ืงื•ื– ืžื”ื“ื ื•ื”ื›ื ืกืชื• ืœืจืงืžื•ืช ื”ื’ื•ืฃ, ืœื™ื™ืฆื•ืจ ื•ืœืื—ืกื•ืŸ ืฉืœ ืื ืจื’ื™ื”. ื›ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื ืžื•ื›ื•ืช, ืœืจื•ื‘ ื‘ืžื”ืœืš ืฆื•ื, ื’ืœื•ืงื’ื•ืŸ ืžืฉื—ืจืจ ื’ืœื•ืงื•ื– ืžื”ื›ื‘ื“ ื›ื“ื™ ืœื”ืขืœื•ืช ืืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื.

ื”ืื˜ืช ื”ืขื™ื›ื•ืœ ื•ื”ื’ื‘ืจืช ืชื—ื•ืฉืช ื”ืฉื•ื‘ืข

GLP-1 ื’ื ืžืื˜ ืืช ื”ืขื™ื›ื•ืœ ื•ืžืขื•ื“ื“ ืชื—ื•ืฉื” ืžืœืื”. ื–ื” ืงื•ืจื” ื›ื™ ื”ื•ื ืžืื˜ ืืช ื”ืงืฆื‘ ืฉื‘ื• ื”ื‘ื˜ืŸ ืžืชืจื•ืงื ืช. ื‘ืขืงื‘ื•ืช ื–ืืช ื”ืชื™ืื‘ื•ืŸ ืคื•ื—ืช, ื•ืœื›ืŸ ืฆืจื™ื›ืช ื”ืžื–ื•ืŸ ื’ื ืคื•ื—ืชืช. ืœื“ื™ื›ื•ื™ ื”ืชื™ืื‘ื•ืŸ ื•ืœืฆืจื™ื›ืช ื”ืื•ื›ืœ ื”ืžื•ืคื—ืชืช ื›ืชื•ืฆืื” ืžื›ืš ื™ืฉ ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืฉื™ื›ื•ืœื•ืช ืœื”ื™ื•ืช ืจืฆื•ื™ื•ืช โ€“ ืฉื™ืคื•ืจ ื”ื•ื•ื™ืกื•ืช ืฉืœ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื•ืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ื‘ืจื™ื.

ื™ืฉ ื›ืžื” ื“ืจื›ื™ื ืœืขื•ื“ื“ ืืช ื”ื™ื™ืฆื•ืจ ืฉืœ ื”ื•ืจืžื•ืŸ GLP-1 ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ื‘ื’ื•ืฃ. ื™ืฉ ื”ืจื‘ื” ืžื–ื•ื ื•ืช ืฉื™ื“ื•ืขื™ื ื‘ื›ืœ ืฉื”ื ืžืขืœื™ื ืืช ื”ืจืžื•ืช ืฉืœ GLP-1. ื ืขื‘ื•ืจ ืขืœ ื”ืžื–ื•ื ื•ืช ื”ืืœื” ืฉืžื’ื‘ื™ืจื™ื ืืช ื”ื™ื™ืฆื•ืจ ืฉืœ GLP-1 ื•ืขื•ื–ืจื™ื ืœื•ื•ืกืช ื‘ืื•ืคืŸ ืงื‘ื•ืข ืืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื•ืœื”ืคื—ื™ืช ืืช ื”ืชื™ืื‘ื•ืŸ. ื”ืฉื™ืœื•ื‘ ื‘ื™ื ื™ื”ื ืขื•ื–ืจ ื‘ืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ื‘ืจื™ื.

6 ืกื•ื’ื™ ืžื–ื•ื ื•ืช ืฉืžืขื•ื“ื“ื™ื ื”ืคืจืฉื” ืฉืœ GLP-1

ื”ื•ื›ื— ืฉืžื–ื•ื ื•ืช ืขืชื™ืจื™ ื—ืœื‘ื•ืŸ, ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ื•ืฉื•ืžื ื™ื ื‘ืจื™ืื™ื ืžื’ื‘ื™ืจื™ื ืืช ื”ื”ืคืจืฉื” ืฉืœ GLP-1 ื‘ืžืขื™. ื’ื ืœื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ื›ืžื• ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ, ื—ื“-ืกื•ื›ืจื™ื ื•ืคืคื˜ื™ื“ื™ื ื™ืฉ ื”ืฉืคืขื” ื—ื™ื•ื‘ื™ืช ืขืœ ื”ื”ืคืจืฉื” ืฉืœื•. ื”ืžื–ื•ื ื•ืช ื”ื‘ืื™ื ืขืชื™ืจื™ื ื‘ื—ื•ืžืจื™ื ื”ืžื–ื™ื ื™ื ื”ืืœื” ื•ื™ื“ื•ืข ืฉื”ื ืžืขืœื™ื ืืช ื”ืจืžื•ืช ืฉืœ ื”ื•ืจืžื•ืŸ GLP-1.

1. ืื‘ื•ืงื“ื•

ืื‘ื•ืงื“ื• ืขืฉื™ืจ ื‘ืฉื•ืžืŸ ื—ื“-ื‘ืœืชื™ ืจื•ื•ื™ ื•ื‘ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื, ื•ืœื›ืŸ ื™ื›ื•ืœ ืœืฉืคืจ ืืช ื”ืจืžื•ืช ืฉืœ GLP-1. ื‘ืžื—ืงืจ ืžืกื•ื™ื ื ืžืฆื ืฉืžื–ื•ื ื•ืช ืฉืขืชื™ืจื™ื ื‘ืฉื•ืžืŸ ื—ื“ ื‘ืœืชื™ ืจื•ื•ื™ ืขืฉื•ื™ื™ื ืœืขื•ื“ื“ ื”ืคืจืฉื” ืฉืœ GLP-1. ื‘ืžื—ืงืจ ืื—ืจ ื ืžืฆื ืฉืื›ื™ืœืช ืื‘ื•ืงื“ื• ืฉืœื ื‘ืืจื•ื—ื” ืžืขืœื” ืืช ื”ืจืžื•ืช ืฉืœ GLP-1 ื•ื‘ื•-ื–ืžื ื™ืช ืžื•ืจื™ื“ื” ืืช ืจืžื•ืช ื”ืื™ื ืกื•ืœื™ืŸ.

ื‘ื ื•ืกืฃ ืœืฉื•ืžื ื™ื ื”ื‘ืจื™ืื™ื, ื™ืฉ ื‘ืื‘ื•ืงื“ื• ื”ืจื‘ื” ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื. ื”ืชื›ื•ืœื” ื”ื’ื‘ื•ื”ื” ืฉืœ ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ื‘ืื‘ื•ืงื“ื• ืขื•ื–ืจืช ืœื”ืื˜ ืืช ื”ืขื™ื›ื•ืœ, ื•ื‘ื›ืš ืœื”ืื˜ ืืช ืงืฆื‘ ื”ืฉื—ืจื•ืจ ืฉืœ ื’ืœื•ืงื•ื– ืžื”ืœื‘ืœื‘ ืืœ ืžื—ื–ื•ืจ ื”ื“ื. ื”ืžืฆื‘ ื”ื–ื” ืขื•ื–ืจ ื‘ื•ื•ื™ืกื•ืช ื”ืจืžื•ืช ืฉืœ ื”ืกื•ื›ืจ ื‘ื“ื ื•ืขืฉื•ื™ ืœืฉืคืจ ืืช ื”ืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ.

ื›ืฉื”ืขื™ื›ื•ืœ ืื™ื˜ื™ ื™ื•ืชืจ, ื™ืฉ ืชื—ื•ืฉืช ืฉื•ื‘ืข ื•ืœื›ืŸ ื”ืชื™ืื‘ื•ืŸ ืคื•ื—ืช. ืขื™ื›ื•ืœ ืžื•ืื˜ ื’ื•ืจื ื’ื ืœืฉื—ืจื•ืจ ื”ื“ืจื’ืชื™ ื™ื•ืชืจ ืฉืœ ื’ืœื•ืงื•ื– ืœืžื—ื–ื•ืจ ื”ื“ื. ื›ืฉื’ืœื•ืงื•ื– ืžืฉืชื—ืจืจ ื‘ื”ื“ืจื’ืชื™ื•ืช, ื”ื”ืคืจืฉื” ืฉืœ GLP-1 ืžื•ื’ื‘ืจืช. ื”ืชื”ืœื™ืš ื”ื–ื” ืขื•ื–ืจ ืžืื•ื“ ืœืฉืžื•ืจ ืขืœ ื”ืžืฉืงืœ ื‘ืฆื•ืจื” ื‘ืจื™ืื”.

ื”ืฆืขื” ืœืžืื›ืœ ื˜ืขื™ื ืœื”ืขืœืืช ื”ืจืžื•ืช ืฉืœ GLP-1: ืžื˜ื‘ืœ ืื‘ื•ืงื“ื• ืžืขื•ืš ืขื ืžืขื˜ ืžืœื— ื•ืžื™ืฅ ืœื™ื™ื ืฉืืคืฉืจ ืœืžืจื•ื— ืขืœ ืฆื ื™ื ืื• ืฆ'ื™ืคืก.

2. ืื’ื•ื–ื™ื

ื‘ื–ื›ื•ืช ื”ืขื•ืฉืจ ื‘ื—ืœื‘ื•ืŸ, ื‘ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ื•ื‘ืฉื•ืžื ื™ื ื‘ืจื™ืื™ื, ืื’ื•ื–ื™ื, ื›ืžื• ืคื™ืกื˜ื•ืงื™ื, ืฉืงื“ื™ื ื•ืื’ื•ื–ื™ ืžืœืš, ื™ื›ื•ืœื™ื ืœื”ืขืœื•ืช ืืช ืจืžื•ืช ื”ื”ืคืจืฉื” ืฉืœ GLP-1. ื‘ื“ื•ืžื” ืœืื‘ื•ืงื“ื•, ื”ืชื›ื•ืœื” ื”ื’ื‘ื•ื”ื” ืฉืœ ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ืขื•ื–ืจืช ืœื”ืื˜ ืืช ื”ืขื™ื›ื•ืœ, ื•ื‘ื›ืš ืœื”ืื˜ ืืช ืฉื—ืจื•ืจ ื”ืื™ื ืกื•ืœื™ืŸ. ื›ืชื•ืฆืื” ืžื›ืš, ื”ื”ืคืจืฉื” ืฉืœ GLP-1 ืžื•ื’ื‘ืจืช.

ื”ื•ื“ื•ืช ืœืฉื•ืžื ื™ื ื”ื‘ืจื™ืื™ื ืฉื™ืฉ ื‘ืื’ื•ื–ื™ื, ื”ืฆืจื™ื›ื” ืฉืœื”ื ื™ื›ื•ืœื” ืœืขื–ื•ืจ ื’ื ืœืจื’ื™ืฉื•ืช ืœืื™ื ืกื•ืœื™ืŸ. ื”ืื’ื•ื–ื™ื ื”ืžื•ืžืœืฆื™ื ื”ืืœื” ืžืžืœืื™ื ืœืžืฉืš ื™ื•ืชืจ ื–ืžืŸ, ื•ื›ืš ืชื—ื•ืฉืช ื”ืฉื•ื‘ื” ืžื•ื’ื‘ืจืช ื•ื”ืชื™ืื‘ื•ืŸ ื•ืฆืจื™ื›ืช ื”ืงืœื•ืจื™ื•ืช ืคื•ื—ืชื™ื.

ื“ืจืš ืžืฆื•ื™ื ืช ืœืฉืœื‘ ืื’ื•ื–ื™ื ื‘ืชื–ื•ื ื” ื”ื™ื ืœื ืฉื ืฉ ื—ื•ืคืŸ ืงื˜ืŸ ืžื“ื™ ืคืขื ืื• ืœื”ื•ืกื™ืฃ ืื•ืชื ืœืกืœื˜ื™ื ืื”ื•ื‘ื™ื ื•ืœื™ื”ื ื•ืช ืžื”ืคืจื™ื›ื•ืช ืฉืœื”ื.

3. ื‘ื™ืฆื™ื

ื‘ื™ืฆื™ื (ื‘ืžื™ื•ื—ื“ ื”ื—ืœื‘ื•ืŸ ืฉืœื”ืŸ) ื”ืŸ ืžืงื•ืจ ืื™ื“ื™ืืœื™ ืœื—ืœื‘ื•ืŸ ื•ืœืฉื•ืžืŸ ื—ื“ ื‘ืœืชื™ ืจื•ื•ื™, ื•ื”ื•ื›ื— ืฉื”ืŸ ืžื’ื‘ื™ืจื•ืช ืืช ื”ื”ืคืจืฉื” ืฉืœ GLP-1.

ื‘ืžื—ืงืจ ืื—ื“ ื ืžืฆื ืฉืื—ืจื™ ืืจื•ื—ื” ืขื ืฉืœื•ืฉ ื‘ื™ืฆื™ื, ื‘ื”ืฉื•ื•ืื” ืœื‘ื™ื™ื’ืœ ืœืืจื•ื—ืช ื‘ื•ืงืจ, ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื”ื™ื• ื ืžื•ื›ื•ืช ื™ื•ืชืจ. ื‘ื ื•ืกืฃ, ื”ืžืฉืชืชืคื™ื ื‘ืžื—ืงืจ ื“ื™ื•ื•ื—ื• ืขืœ ื”ืคื—ืชื” ื‘ืฆืจื™ื›ืช ื”ืžื–ื•ืŸ ื•ื‘ืชื—ื•ืฉืช ื”ืจืขื‘ ื‘ืžืฉืš 24 ื”ืฉืขื•ืช ืฉืœืื—ืจ ืžื›ืŸ.

ื›ื“ืื™ ืœื ืกื•ืช ืœื”ืชื—ื™ืœ ืืช ื”ื™ื•ื ืขื ื—ื‘ื™ืชืช ื™ืจืง ืื• ื›ืžื” ื‘ื™ืฆื™ื ืงืฉื•ืช, ื•ื›ืš ืœืชืจื•ื ืœืฉื™ืคื•ืจ ื”ื”ืคืจืฉื” ืฉืœ GLP-1.

4. ื“ื’ื ื™ื

ื›ืฉื“ื’ื ื™ื ืขืชื™ืจื™ ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ืชื•ืกืกื™ื ื‘ืžืขื™, ื”ื ืชื•ืจืžื™ื ืœื™ื™ืฆื•ืจ ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืงืฆืจื•ืช ืฉืจืฉืจืช (SCFA), ื›ื•ืœืœ ื‘ื•ื˜ื™ืจื˜, ืืฆื˜ื˜ ื•ืคืจื•ืคื™ื•ื ื˜. ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืงืฆืจื•ืช ืฉืจืฉืจืช ื™ื›ื•ืœื•ืช ืœืขื•ื“ื“ ื”ืคืจืฉืช GLP-1 ื›ื™ ื”ืŸ ื ืงืฉืจื•ืช ืœืงื•ืœื˜ื ื™ื ืฉืœ ืชืื™ L.

ื”ืกื™ื‘ื™ื ื”ืชื–ื•ื ืชื™ื™ื ื‘ื“ื’ื ื™ื ื’ื ืขื•ื–ืจื™ื ืœื”ืื˜ ืืช ื”ืขื™ื›ื•ืœ, ื•ื‘ื›ืš ื’ื•ืจืžื™ื ืœืฉื—ืจื•ืจ ื”ื“ืจื’ืชื™ ืฉืœ ื’ืœื•ืงื•ื– ืฉืžื•ื‘ื™ืœ ืœื”ืคืจืฉืช GLP-1.

ืืคืฉืจ ืœื”ืชื—ื™ืœ ืืช ื”ื™ื•ื ืขื ืงืขืจื” ืฉืœ ื“ื™ื™ืกืช ืฉื™ื‘ื•ืœืช ืฉื•ืขืœ ืื• ืคืจื•ืกืช ืœื—ื ืžื—ื™ื˜ื” ืžืœืื” ื›ื“ื™ ืœื”ืขืœื•ืช ืืช ื”ืจืžื•ืช ืฉืœ ื”ื•ืจืžื•ืŸ GLP-1. ื’ื ื“ื’ื ื™ื ืžืœืื™ื ืื—ืจื™ื, ื›ืžื• ืฉืขื•ืจื”, ืฉื™ืคื•ืŸ, ื“ื•ื—ืŸ ื•ื›ื•ืกืžืช, ืขืฉื™ืจื™ื ื‘ืกื™ื‘ื™ื ืžืกื™ืกื™ื ื•ืชื•ืจืžื™ื ืœืชื—ื•ืฉืช ืฉื•ื‘ืข ื•ืœื”ืคืจืฉืช GLP-1.

5. ืฉืžืŸ ื–ื™ืช

ื”ืจื‘ื” ืžื—ืงืจื™ื ื”ืจืื• ืื™ืš ืชื–ื•ื ื” ืฉืขืฉื™ืจื” ื‘ืฉืžืŸ ื–ื™ืช ืžืฉืคื™ืขื” ืœื˜ื•ื‘ื” ืขืœ ืจืžื•ืช GLP-1. ืื—ื“ ืžื”ืžื—ืงืจื™ื ื”ืืœื” ื”ืจืื” ืฉืืฆืœ ืื ืฉื™ื ืขื ืชื–ื•ื ื” ืฉืขืฉื™ืจื” ื‘ืฉืžืŸ ื–ื™ืช, ื”ืจืžื•ืช ืฉืœ GLP-1 ืื—ืจื™ ื”ืืจื•ื—ื” ื”ื™ื• ื’ื‘ื•ื”ื•ืช ื™ื•ืชืจ. ื‘ืื•ืชื• ืžื—ืงืจ ื”ืจืื• ืฉืืฆืœ ืื ืฉื™ื ืขื ืชื–ื•ื ื” ืขืฉื™ืจื” ื‘ืฉืžืŸ ื–ื™ืช ื™ืฉ ืจืžื•ืช ื’ืœื•ืงื•ื– ื ืžื•ื›ื•ืช ื™ื•ืชืจ, ื’ื ืื—ืจื™ ืื›ื™ืœื” ื•ื’ื ื‘ืฆื•ื, ื•ื’ื ื”ืจื’ื™ืฉื•ืช ืœืื™ื ืกื•ืœื™ืŸ ืžืฉื•ืคืจืช.

ื‘ืžื—ืงืจ ืื—ืจ ืžืฆืื• ืฉืืฆืœ ืขื›ื‘ืจื™ื ืฉืฆืจื›ื• ืฉืžืŸ ื–ื™ืช ื‘ืื•ืคืŸ ืงื‘ื•ืข ื›ื—ืœืง ืžื”ืชื–ื•ื ื” ืฉืœื”ื, ื”ืคืจืฉืช GLP-1 ื”ื•ื’ื‘ืจื” ื•ื”ื™ื” ืฉื™ืคื•ืจ ื‘ืกื‘ื™ืœื•ืช ืœื’ืœื•ืงื•ื–. ืืฆืœ ืขื›ื‘ืจื™ื ืกื•ื›ืจืชื™ื™ื, ื”ืžื—ืงืจ ื”ืจืื” ืฉืชื–ื•ื ื” ืขืชื™ืจืช ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ื—ื“ ื‘ืœืชื™ ืจื•ื•ื™ื•ืช ืฉืžืงื•ืจืŸ ื‘ืฉืžืŸ ื–ื™ืช ื”ื•ื‘ื™ืœื” ืœืคื—ื•ืช ื”ืขืœืื” ื‘ืžืฉืงืœ, ืœืฉื™ืคื•ืจ ื‘ืจื’ื™ืฉื•ืช ืœืื™ื ืกื•ืœื™ืŸ ื•ืœื”ืขืœืืช ื”ืจืžื•ืช ืฉืœ GLP-1.

ื›ื“ื™ ืœื™ื”ื ื•ืช ืžื”ื”ืฉืคืขื” ื”ื—ื™ื•ื‘ื™ืช ืฉื™ืฉ ืœืžื–ื•ืŸ-ื”ืขืœ ื”ื–ื” ืขืœ GLP-1, ื›ื“ืื™ ืœื”ืงืคื™ืฅ ื™ืจืงื•ืช ืื”ื•ื‘ื™ื ื‘ืฉืžืŸ ื–ื™ืช ืื• ืœื”ื–ืœื™ืฃ ืงืฆืช ืขืœ ืกืœื˜ ืื• ื‘ื›ืจื™ืš.

6. ื™ืจืงื•ืช

ื™ืจืงื•ืช ืขืฉื™ืจื™ื ื‘ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื, ื›ืžื• ืืกืคืจื’ื•ืก, ื‘ืจื•ืงื•ืœื™, ืืจื˜ื™ืฉื•ืง, ืกืœืจื™ ื•ืขื•ื“, ื™ื›ื•ืœื™ื ืœืขื–ื•ืจ ืœื”ืขืœื•ืช ืืช ื”ืจืžื•ืช ืฉืœ GLP-1, ื•ืœืคืขืžื™ื ื’ื ืขื•ื–ืจื™ื ื‘ื•ื•ื™ืกื•ืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื.

ื‘ืžื—ืงืจ ืื—ื“ ื ืžืฆื ืฉืฆืจื™ื›ืช ื™ืจืงื•ืช ืœืคื ื™ ืื›ื™ืœืช ืคื—ืžื™ืžื•ืช ืžืฉืคื™ืขื” ื‘ืื•ืคืŸ ืžืฉืžืขื•ืชื™ ืขืœ ื”ืจืžื•ืช ืฉืœ GLP-1 ื•ื’ืœื•ืงื•ื– ืืฆืœ ืžื˜ื•ืคืœื™ื ืขื ืกื•ื›ืจืช ืžืกื•ื’ 2. ื”ืฉื™ื ื•ื™ ื”ื›ื™ ืžืฉืžืขื•ืชื™ ื ืจืฉื 60 ื“ืงื•ืช ืื—ืจื™ ืืจื•ื—ื”.

ืืคืฉืจ ืœื”ื›ื™ืŸ ื›ืžื” ื™ืจืงื•ืช ืฆื‘ืขื•ื ื™ื™ื ืขื ืฉืžืŸ ื–ื™ืช ื•ืžืขื˜ ืžืœื— ื‘ืžื›ืฉื™ืจ ื˜ื™ื’ื•ืŸ ืœืœื ืฉืžืŸ, ื•ืœื™ื”ื ื•ืช ืžืชื•ืกืคืช ื˜ืขื™ืžื” ื•ืžื–ื™ื ื” ืฉืขื•ื–ืจืช ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช ื‘ืจื™ืื•ืช ืฉืœ ื”ื•ืจืžื•ืŸ GLP-1 ื•ื’ืœื•ืงื•ื– ื‘ื“ื.

ืžื–ื•ื ื•ืช ืฉืขื“ื™ืฃ ืœื”ื™ืžื ืข ืžื”ื

ืžื–ื•ื ื•ืช ืขืชื™ืจื™ ื—ืœื‘ื•ืŸ, ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ื•ืฉื•ืžื ื™ื ื‘ืจื™ืื™ื ืขื•ื–ืจื™ื ืœื”ื’ื‘ื™ืจ ืืช ื”ื”ืคืจืฉื” ืฉืœ GLP-1, ืื‘ืœ ืžื–ื•ื ื•ืช ืื—ืจื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืคื™ืข ืœืจืขื” ืขืœ ื”ื”ืคืจืฉื” ืฉืœ GLP-1.

ืžื–ื•ื ื•ืช ืขืชื™ืจื™ื ื‘ืกื•ื›ืจ

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช ืื•ืคื˜ื™ืžืœื™ื•ืช ืฉืœ GLP-1, ืขื“ื™ืฃ ืœื”ื™ืžื ืข ืžื—ื˜ื™ืคื™ื ื•ืžืžืฉืงืื•ืช ืžืžื•ืชืงื™ื. ืžืฉืงืื•ืช ืžื•ื’ื–ื™ื ื•ื—ื˜ื™ืคื™ื ืžืชื•ืงื™ื, ื›ืžื• ืžืžืชืงื™ื ื•ืขื•ื’ื™ื•ืช, ืขืœื•ืœื™ื ืœื’ืจื•ื ืœืขืœื™ื•ืช ื—ื“ื•ืช ื‘ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื•ื›ืš ืœื”ืฉืคื™ืข ืœืจืขื” ืขืœ ื”ื”ืคืจืฉื” ืฉืœ GLP-1. ืขื“ื™ืฃ ืœืฆืจื•ืš ืžืฉืงืื•ืช ืœื ืžืžื•ืชืงื™ื, ืžื™ื, ืื’ื•ื–ื™ื, ื™ืจืงื•ืช ื—ืชื•ื›ื™ื ื•ืชื” ืฆืžื—ื™ื, ื’ื ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช ื‘ืจื™ืื•ืช ืฉืœ GLP-1 ื•ื’ืœื•ืงื•ื– ื•ื’ื ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืžืฉืงืœ ื‘ืจื™ื.

ืฉื•ืžืŸ ื˜ืจืื ืก

ืžืืคื™ื ืงื ื•ื™ื™ื ื•ืžื–ื•ื ื•ืช ืžื˜ื•ื’ื ื™ื ืขืชื™ืจื™ื ื‘ืฉื•ืžืŸ ื˜ืจืื ืก. ืฉื•ืžืŸ ื˜ืจืื ืก ืคื•ื’ื ื‘ืจื’ื™ืฉื•ืช ืœืื™ื ืกื•ืœื™ืŸ ื•ืžืคื—ื™ืช ืืช ื”ื”ืคืจืฉื” ืฉืœ GLP-1.

ืขื“ื™ืฃ ืœืื›ื•ืœ ืžื–ื•ื ื•ืช ืืคื•ื™ื™ื, ืžื•ืงืคืฆื™ื ืื• ืžืื›ืœื™ื ืฉื”ื•ื›ื ื• ื‘ืžื›ืฉื™ืจ ื˜ื™ื’ื•ืŸ ื‘ืœื™ ืฉืžืŸ, ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช ืื•ืคื˜ื™ืžืœื™ื•ืช ืฉืœ ื”ืคืจืฉืช GLP-1 ื•ื’ืœื•ืงื•ื–. ืœืžืจื•ืช ื”ื ื•ื—ื•ืช ืฉืœ ืžืืคื™ื ืงื ื•ื™ื™ื, ื”ื ืคื—ื•ืช ื‘ืจื™ืื™ื, ืœื›ืŸ ื›ื“ืื™ ืœื•ื•ืชืจ ืขืœื™ื”ื ื•ืœื”ื›ื™ืŸ ืžืืคื™ื ื‘ื‘ื™ืช.

ืžื–ื•ื ื•ืช ืžืขื•ื‘ื“ื™ื

ืคื—ืžื™ืžื•ืช ืžื–ื•ืงืงื•ืช ื•ืฉื•ืžื ื™ื ืœื ื‘ืจื™ืื™ื ื”ื ืจื›ื™ื‘ื™ื ื ืคื•ืฆื™ื ืฉืœ ืžื–ื•ื ื•ืช ืžืขื•ื‘ื“ื™ื. ืืœื” ืฉื ื™ ืจื›ื™ื‘ื™ื ืœื ืจืฆื•ื™ื™ื ืฉืขืœื•ืœื™ื ืœื”ืคืจื™ืข ืœื™ื™ืฆื•ืจ ืฉืœ GLP-1 ื•ืœื•ื•ื™ืกื•ืช ืฉืœ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื.

ื›ื“ื™ ืœืืžืฅ ื”ืจื’ืœื™ื ื˜ื•ื‘ื™ื ืœืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ื‘ืจื™ื, ืขื“ื™ืฃ ืœืื›ื•ืœ ืžื–ื•ื ื•ืช ืžืœืื™ื ื•ืœื ืžืขื•ื‘ื“ื™ื. ืœื“ื•ื’ืžื”, ืืจื•ื—ืช ืฆื”ืจื™ื™ื ืฉืœ ื—ื–ื” ืขื•ืฃ ืืคื•ื™ ื•ื’ื–ืจื™ื ืžืื•ื“ื™ื ืขื“ื™ืคื” ืขืœ ื˜ื•ืกื˜ ื ืงื ื™ืง ื•ืฆ'ื™ืคืก.

ืืœื›ื•ื”ื•ืœ

ืœืฆืจื™ื›ืช ืืœื›ื•ื”ื•ืœ ืžืชื•ื ื” ืื™ืŸ ื”ืฉืคืขื” ืžืฉืžืขื•ืชื™ืช ืขืœ ื”ืจืžื•ืช ืฉืœ GLP-1, ืื‘ืœ ืฆืจื™ื›ืช ืืœื›ื•ื”ื•ืœ ืžื•ืคืจื–ืช ืขืœื•ืœื” ืœื’ืจื•ื ืœื—ื•ืกืจ ืื™ื–ื•ืŸ ื‘ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ื•ืœื”ืคื—ื™ืช ืืช ื”ื™ื™ืฆื•ืจ ืฉืœ GLP-1.

ืจืฆื•ื™ ืœื”ื’ื‘ื™ืœ ืืช ืฆืจื™ื›ืช ื”ืืœื›ื•ื”ื•ืœ ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช ื‘ืจื™ืื•ืช ืฉืœ ืกื•ื›ืจ ื‘ื“ื ื•ื”ืคืจืฉืช GLP-1 ื‘ืžื™ื“ื” ืื•ืคื˜ื™ืžืœื™ืช.

ื”ืชืžื•ื ื” ื”ื’ื“ื•ืœื”

ืœืคื™ ืžื—ืงืจื™ื, ื‘ืขื–ืจืช ืฉื™ื ื•ื™ื™ื ื‘ืชื–ื•ื ื” ืฉืชื•ืžื›ื™ื ื‘ื™ื›ื•ืœืช ื”ื˜ื‘ืขื™ืช ืฉืœ ื”ื’ื•ืฃ ืœื”ืคืจื™ืฉ GLP-1 ืืคืฉืจ ืœื ื”ืœ ื‘ื™ืขื™ืœื•ืช ืžืฆื‘ื™ื ื›ืžื• ื”ืฉืžื ืช ื™ืชืจ ื•ืกื•ื›ืจืช ืžืกื•ื’ 2.

ืžื–ื•ื ื•ืช ืขืชื™ืจื™ ื—ืœื‘ื•ืŸ, ืฉื•ืžื ื™ื ื‘ืจื™ืื™ื ื•ืกื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื, ื›ืžื• ื‘ื™ืฆื™ื, ื“ื’ื ื™ื ืžืœืื™ื, ืื’ื•ื–ื™ื ื•ื™ืจืงื•ืช, ื™ื›ื•ืœื™ื ืœืขื–ื•ืจ ืœืฉืžื•ืจ ืขืœ ืจืžื•ืช GLP-1 ืื•ืคื˜ื™ืžืœื™ื•ืช. ื”ืฉืžื™ืจื” ืขืœ ืจืžื•ืช ื‘ืจื™ืื•ืช ืฉืœ GLP-1 ื™ื›ื•ืœื” ืœืขื–ื•ืจ ื‘ื ื™ื”ื•ืœ ืกื•ื›ืจืช ื•ืœืขื•ื“ื“ ืชื—ื•ืฉืช ืžืœืื•ืช, ื•ื›ืš ืœืงื“ื ืื•ืชืš ืœื™ืขื“ื™ื ื”ื›ืœืœื™ื™ื ืœืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ื‘ืจื™ื. ื”ื•ืจืžื•ืŸ GLP-1 ืžืขื•ื“ื“ ืฉื—ืจื•ืจ ืื™ื ืกื•ืœื™ืŸ ื•ืžืคื—ื™ืช ื”ืคืจืฉืช ื’ืœื•ืงื’ื•ืŸ, ื•ืœื›ืŸ ื™ืฉ ืœื• ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ืชื”ืœื™ืš ื”ื™ื™ืฆื•ืจ ื•ื”ื”ืคืจืฉื” ืืฆืœ ื›ืœ ืžื™ ืฉืจื•ืฆื” ืœื ื”ืœ ืืช ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื ืื• ืœืฉืžื•ืจ ืขืœ ืžืฉืงืœ ื‘ืจื™ื. GLP-1 ืžืฉืชื—ืจืจ ื‘ืžืขื™ ืื—ืจื™ ื”ืื•ื›ืœ, ืœื›ืŸ ื›ื“ืื™ ืœื‘ื—ื•ืจ ืžื–ื•ื ื•ืช ืžืชืื™ืžื™ื ืฉื™ืขื•ื“ื“ื• ืืช ื”ืฉื—ืจื•ืจ ืฉืœื• ื•ืœื”ื™ืžื ืข ืžืžื–ื•ื ื•ืช ืฉื™ืฉืคื™ืขื• ืœืจืขื” ืขืœ ื”ืคืจืฉืช GLP-1.

ืจืฉื™ืžืช ื”ืžืงื•ืจื•ืช:

  1. Bodnaruc, A.M., Prudโ€™homme, D., Blanchet, R. et al. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review. Nutr Metab (Lond) 13, 92 (2016).
  2. Zhu L, Huang Y, Edirisinghe I, Park E, Burton-Freeman B. Using the Avocado to Test the Satiety Effects of a Fat-Fiber Combination in Place of Carbohydrate Energy in a Breakfast Meal in Overweight and Obese Men and Women: A Randomized Clinical Trial. Nutrients. 2019 Apr 26;11(5):952. doi: 10.3390/nu11050952. PMID: 31035472; PMCID: PMC6567160.
  3. Hira T, Trakooncharoenvit A, Taguchi H, Hara H. Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity. Int J Mol Sci. 2021 Jun 21;22(12):6623. doi: 10.3390/ijms22126623. PMID: 34205659; PMCID: PMC8235588.
  4. Indarto, D., Rochmah, D. N., Wiboworini, B., Pratama, Y. M., & Wibowo, Y. C. (2022). Effects of Vegetables Consumption Before Carbohydrates on Blood Glucose and GLP-1 Levels Among Diabetic Patients in Indonesia. International journal of preventive medicine, 13, 144. https://doi.org/10.4103/ijpvm.IJPVM70420

โ€‹ื›ืชื‘ ื•ื™ืชื•ืจ:โ€‹ ืžืจื›ื– ื”ื‘ืจื™ืื•ืช ื”ื–ื” ืœื ื ื•ืขื“ ืœืื‘ื—ืŸ,,, โ€‹ื”ืฆื’ ืขื•ื“